UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

PTEN and Gynecological Cancers

Cancers, 2019-09, Vol.11 (10), p.1458

2019

Link zum Volltext

Verfügbarkeit prüfen

Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY)

American journal of obstetrics and gynecology, 2019-10, Vol.221 (4), p.324.e1-324.e10

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine

Journal of experimental & clinical cancer research, 2021-03, Vol.40 (1), p.116-116, Article 116

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

Cancers, 2021-04, Vol.13 (9), p.2089

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study)

Scientific reports, 2020-10, Vol.10 (1), p.16511-16511, Article 16511

2020

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment

Frontiers in oncology, 2021-09, Vol.11, p.612450-612450

2021

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

Cancers, 2021-03, Vol.13 (6), p.1298

2021

Link zum Volltext

Verfügbarkeit prüfen

Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience

Journal of minimally invasive gynecology, 2018-05, Vol.25 (4), p.644-650

2018

Link zum Volltext

Verfügbarkeit prüfen

One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer

PloS one, 2018-04, Vol.13 (4), p.e0195877-e0195877

2018

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors Resistance: Mechanisms and Perspectives

Cancers, 2022-03, Vol.14 (6), p.1420

2022

Link zum Volltext

Verfügbarkeit prüfen

Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids

Journal of experimental & clinical cancer research, 2023-05, Vol.42 (1), p.126-126, Article 126

2023

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers

European radiology experimental, 2023-09, Vol.7 (1), p.50-50, Article 50

2023

Link zum Volltext

Verfügbarkeit prüfen

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives

Frontiers in oncology, 2022-02, Vol.12, p.831612-831612

2022

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients

Cancers, 2021-10, Vol.13 (20), p.5200

2021

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node biopsy in ovarian cancer: more questions than certainties

International journal of gynecological cancer, 2023-10, Vol.33 (10), p.1502-1503

2023

Link zum Volltext

Verfügbarkeit prüfen

Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations

Annals of surgical oncology, 2014-07, Vol.21 (7), p.2369-2375

2014

Link zum Volltext

Verfügbarkeit prüfen

L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma

Cancers, 2022-07, Vol.14 (15), p.3635

2022

Link zum Volltext

Verfügbarkeit prüfen

Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital

Journal of personalized medicine, 2024-04, Vol.14 (4), p.371

2024

Link zum Volltext

Verfügbarkeit prüfen

Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center

Journal of personalized medicine, 2022-10, Vol.12 (10), p.1746

2022

Link zum Volltext

Verfügbarkeit prüfen

Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience

Surgical endoscopy, 2014-01, Vol.28 (6), p.1808-1815

2014

Link zum Volltext

Verfügbarkeit prüfen

Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital

Journal of personalized medicine, 2021-12, Vol.12 (1), p.3

2021

Link zum Volltext

Verfügbarkeit prüfen

Integration of PARP-inhibitors in ovarian cancer therapy

Exploration of targeted anti-tumor therapy, 2020-01, Vol.1 (3), p.171-182

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(76)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

PTEN and Gynecological Cancers

Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY)

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine

Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study)

Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment

Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience

One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer

PARP Inhibitors Resistance: Mechanisms and Perspectives

Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids

Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers

Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives

PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients

Sentinel lymph node biopsy in ovarian cancer: more questions than certainties

A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants

Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations

L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma

Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital

Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center

Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience

Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital

Integration of PARP-inhibitors in ovarian cancer therapy

Suchergebnisse filtern